The Role of Alpha 6 Integrin in Prostate Cancer Migration and Bone Pain
Author Information
Author(s): King Tamara E., Pawar Sangita C., Majuta Lisa, Sroka Isis C., Wynn Danyel, Demetriou Manolis C., Nagle Raymond B., Porreca Frank, Cress Anne E.
Primary Institution: The Arizona Cancer Center, University of Arizona
Hypothesis
Can blocking the cleavage of the A6 integrin adhesion receptor prevent cancer-induced bone pain?
Conclusion
Blocking the cleavage of the A6 integrin on prostate tumor cells significantly reduces bone loss and cancer-induced pain.
Supporting Evidence
- More than 50% of prostate cancer patients develop severe bone pain during their lifetime.
- Blocking A6 integrin cleavage reduced tumor cell migration and bone pain.
- Mice with mutated integrin showed less bone loss and fewer fractures.
Takeaway
This study found that a special part of cancer cells can be blocked to stop them from causing pain in bones, which is important for people with prostate cancer.
Methodology
A xenograft mouse model was used to study the effects of human prostate cancer cells expressing either wild-type or mutated A6 integrin on bone pain and migration.
Limitations
The study was conducted in a mouse model, which may not fully replicate human conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website